Andre Kalil, MD MPH
@drandrekalil.bsky.social
Practicing Doc, Transplant ID Director, ID/Critical Care, Clinical Researcher & Trialist. Professor, University of Nebraska Medical Center, Omaha.
Pinned
Hope to learn and share scientific knowledge within this new space.
Reposted by Andre Kalil, MD MPH
We already know ESR/CRP are zombie tests...this SRMA suggests that their role in the definition of PJI is questionable given their lack of sensitivity/specificity, etc. Same with other inflammatory markers like IL-6
@cortes-penfield.bsky.social was part of a workgroup for the Unified PJI Definition Taskforce, which published this systematic review and meta-analysis on the role of inflammatory markers for PJI #IDSky #OrthoID
pubmed.ncbi.nlm.nih.gov/41230391/
pubmed.ncbi.nlm.nih.gov/41230391/
Serum inflammatory markers for the screening and diagnosis of periprosthetic joint infection: a systematic review and meta-analysis - PubMed
<span><b>Aim</b>: As part of a multi-society effort to derive a unified consensus definition of periprosthetic joint infection (PJI), a systematic review of serum inflammatory marker diagnostic performance for hip, knee, and shoulder PJI was performed. <b>Methods</b>: PubMed (MEDLINE) and EMBASE were sear</span> …
pubmed.ncbi.nlm.nih.gov
November 14, 2025 at 3:05 PM
We already know ESR/CRP are zombie tests...this SRMA suggests that their role in the definition of PJI is questionable given their lack of sensitivity/specificity, etc. Same with other inflammatory markers like IL-6
Reposted by Andre Kalil, MD MPH
@cortes-penfield.bsky.social was part of a workgroup for the Unified PJI Definition Taskforce, which published this systematic review and meta-analysis on the role of inflammatory markers for PJI #IDSky #OrthoID
pubmed.ncbi.nlm.nih.gov/41230391/
pubmed.ncbi.nlm.nih.gov/41230391/
Serum inflammatory markers for the screening and diagnosis of periprosthetic joint infection: a systematic review and meta-analysis - PubMed
<span><b>Aim</b>: As part of a multi-society effort to derive a unified consensus definition of periprosthetic joint infection (PJI), a systematic review of serum inflammatory marker diagnostic performance for hip, knee, and shoulder PJI was performed. <b>Methods</b>: PubMed (MEDLINE) and EMBASE were sear</span> …
pubmed.ncbi.nlm.nih.gov
November 14, 2025 at 3:03 PM
@cortes-penfield.bsky.social was part of a workgroup for the Unified PJI Definition Taskforce, which published this systematic review and meta-analysis on the role of inflammatory markers for PJI #IDSky #OrthoID
pubmed.ncbi.nlm.nih.gov/41230391/
pubmed.ncbi.nlm.nih.gov/41230391/
Reposted by Andre Kalil, MD MPH
Drs. Natalia Castillo, @drandrekalil.bsky.social & Carlos Gomez published this interesting case report of a prostatic abscess from Ureaplsma parvum in a patient with a heart transplant using NGS #IDSky
onlinelibrary.wiley.com/doi/10.1155/...
onlinelibrary.wiley.com/doi/10.1155/...
Prostatic Abscess due to Ureaplasma parvum in a Heart Transplant Recipient: Diagnostic Challenges and Clinical Utility of Metagenomics Next‐Generation Sequencing (NGS)
Ureaplasma spp. are small and fastidious bacteria that may cause urogenital infections in healthy adults and, in rare cases, invasive disease. These bacteria have been increasingly recognized in immu...
onlinelibrary.wiley.com
November 14, 2025 at 3:08 PM
Drs. Natalia Castillo, @drandrekalil.bsky.social & Carlos Gomez published this interesting case report of a prostatic abscess from Ureaplsma parvum in a patient with a heart transplant using NGS #IDSky
onlinelibrary.wiley.com/doi/10.1155/...
onlinelibrary.wiley.com/doi/10.1155/...
Aurora Borealis in Omaha-Nebraska tonight is quite an amazing view!
November 13, 2025 at 5:20 AM
Aurora Borealis in Omaha-Nebraska tonight is quite an amazing view!
Reposted by Andre Kalil, MD MPH
Just 4 weeks to CCR Down Under 2025!
Join us to hear the results of 8 major critical care trials - in person or virtually
➡️ ImmunoSep
➡️ iRehab
➡️ CLIP II
➡️ ACTiVE
➡️ ARISE AFRICA
➡️ RSI
➡️ VITaCCA
➡️ ECMO REHAB
https://criticalcarereviews.com/meetings/ccr-down-under-2025
Join us to hear the results of 8 major critical care trials - in person or virtually
➡️ ImmunoSep
➡️ iRehab
➡️ CLIP II
➡️ ACTiVE
➡️ ARISE AFRICA
➡️ RSI
➡️ VITaCCA
➡️ ECMO REHAB
https://criticalcarereviews.com/meetings/ccr-down-under-2025
November 11, 2025 at 10:10 PM
Just 4 weeks to CCR Down Under 2025!
Join us to hear the results of 8 major critical care trials - in person or virtually
➡️ ImmunoSep
➡️ iRehab
➡️ CLIP II
➡️ ACTiVE
➡️ ARISE AFRICA
➡️ RSI
➡️ VITaCCA
➡️ ECMO REHAB
https://criticalcarereviews.com/meetings/ccr-down-under-2025
Join us to hear the results of 8 major critical care trials - in person or virtually
➡️ ImmunoSep
➡️ iRehab
➡️ CLIP II
➡️ ACTiVE
➡️ ARISE AFRICA
➡️ RSI
➡️ VITaCCA
➡️ ECMO REHAB
https://criticalcarereviews.com/meetings/ccr-down-under-2025
Reposted by Andre Kalil, MD MPH
#Antimicrobials2026
Don’t miss Symposium 2! 🎯 Better Diagnostics, Optimal Treatment
💊@angelahuttner.bsky.social Biomarkers of Infection
💊Lito Papanicolas: Can AMS Protect your Microbiome?
💊Krispin Hajkowicz: Metagenomics
Register now: www.antimicrobials.com.au
#idsky #amssky #microsky #medsky
Don’t miss Symposium 2! 🎯 Better Diagnostics, Optimal Treatment
💊@angelahuttner.bsky.social Biomarkers of Infection
💊Lito Papanicolas: Can AMS Protect your Microbiome?
💊Krispin Hajkowicz: Metagenomics
Register now: www.antimicrobials.com.au
#idsky #amssky #microsky #medsky
October 23, 2025 at 6:11 AM
#Antimicrobials2026
Don’t miss Symposium 2! 🎯 Better Diagnostics, Optimal Treatment
💊@angelahuttner.bsky.social Biomarkers of Infection
💊Lito Papanicolas: Can AMS Protect your Microbiome?
💊Krispin Hajkowicz: Metagenomics
Register now: www.antimicrobials.com.au
#idsky #amssky #microsky #medsky
Don’t miss Symposium 2! 🎯 Better Diagnostics, Optimal Treatment
💊@angelahuttner.bsky.social Biomarkers of Infection
💊Lito Papanicolas: Can AMS Protect your Microbiome?
💊Krispin Hajkowicz: Metagenomics
Register now: www.antimicrobials.com.au
#idsky #amssky #microsky #medsky
Reposted by Andre Kalil, MD MPH
New on The SHEA Podcast!
Dr. Jonathan Ryder and Dr. Aditi Ramakrishnan discuss the intersection of sexually transmitted infections and antimicrobial stewardship.
Listen now: bit.ly/488Ar9I
Dr. Jonathan Ryder and Dr. Aditi Ramakrishnan discuss the intersection of sexually transmitted infections and antimicrobial stewardship.
Listen now: bit.ly/488Ar9I
October 17, 2025 at 9:08 PM
New on The SHEA Podcast!
Dr. Jonathan Ryder and Dr. Aditi Ramakrishnan discuss the intersection of sexually transmitted infections and antimicrobial stewardship.
Listen now: bit.ly/488Ar9I
Dr. Jonathan Ryder and Dr. Aditi Ramakrishnan discuss the intersection of sexually transmitted infections and antimicrobial stewardship.
Listen now: bit.ly/488Ar9I
Reposted by Andre Kalil, MD MPH
Our ID division is well represented at #IDWeek2025, come find us at a talk or a poster!
@idweek.bsky.social @idsainfo.bsky.social #IDSky
blog.unmc.edu/infectious-d...
@idweek.bsky.social @idsainfo.bsky.social #IDSky
blog.unmc.edu/infectious-d...
UNMC Infectious Diseases Shines at IDWeek 2025 - Division of Infectious Diseases
Atlanta, GA | October 19–22, 2025The infectious diseases community is gathering once again for IDWeek 2025, and the University of Nebraska Medical Center (UNMC) Division of Infectious Diseases is prou...
blog.unmc.edu
October 14, 2025 at 6:05 PM
Our ID division is well represented at #IDWeek2025, come find us at a talk or a poster!
@idweek.bsky.social @idsainfo.bsky.social #IDSky
blog.unmc.edu/infectious-d...
@idweek.bsky.social @idsainfo.bsky.social #IDSky
blog.unmc.edu/infectious-d...
💥🆕“Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients—Promise, Pitfalls, and Path Forward”
👇Free Access
bit.ly/3KzihEu
@cmijournal.bsky.social #IDSky #MedSky #PCCSky #EMIMC #AMSSky #TxID #meded #Pharmsky #RXSky #MicroSky #ClinMicro @unmc.bsky.social @unmc-id.bsky.social
👇Free Access
bit.ly/3KzihEu
@cmijournal.bsky.social #IDSky #MedSky #PCCSky #EMIMC #AMSSky #TxID #meded #Pharmsky #RXSky #MicroSky #ClinMicro @unmc.bsky.social @unmc-id.bsky.social
Plasma microbial cell-free DNA sequencing in transplant and haematologic patients—promise, pitfalls, and path forward
bit.ly
October 8, 2025 at 10:58 PM
💥🆕“Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients—Promise, Pitfalls, and Path Forward”
👇Free Access
bit.ly/3KzihEu
@cmijournal.bsky.social #IDSky #MedSky #PCCSky #EMIMC #AMSSky #TxID #meded #Pharmsky #RXSky #MicroSky #ClinMicro @unmc.bsky.social @unmc-id.bsky.social
👇Free Access
bit.ly/3KzihEu
@cmijournal.bsky.social #IDSky #MedSky #PCCSky #EMIMC #AMSSky #TxID #meded #Pharmsky #RXSky #MicroSky #ClinMicro @unmc.bsky.social @unmc-id.bsky.social
Reposted by Andre Kalil, MD MPH
Drs. Gomez, Scherger, Abbas & @drandrekalil.bsky.social published a fascinating paper in @cmijournal.bsky.social on novel diagnostic testing:
"Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients-Promise, Pitfalls, and Path Forward"
pubmed.ncbi.nlm.nih.gov/40946803/
"Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients-Promise, Pitfalls, and Path Forward"
pubmed.ncbi.nlm.nih.gov/40946803/
Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients-Promise, Pitfalls, and Path Forward - PubMed
Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients-Promise, Pitfalls, and Path Forward
pubmed.ncbi.nlm.nih.gov
September 25, 2025 at 7:50 PM
Drs. Gomez, Scherger, Abbas & @drandrekalil.bsky.social published a fascinating paper in @cmijournal.bsky.social on novel diagnostic testing:
"Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients-Promise, Pitfalls, and Path Forward"
pubmed.ncbi.nlm.nih.gov/40946803/
"Plasma Microbial Cell-Free DNA Sequencing in Transplant and Hematologic Patients-Promise, Pitfalls, and Path Forward"
pubmed.ncbi.nlm.nih.gov/40946803/
Reposted by Andre Kalil, MD MPH
The 2nd #Communicable & #Breakpoints collaboration drops on 19 Sept! Hosts @angelahuttner.bsky.social & @erinmccreary.bsky.social invite BALANCE trial leads Nick Daneman & Robert Fowler to discuss everything from the trial's humble start to its meteoric impact in clinical practice.
#IDSky #clinmicro
#IDSky #clinmicro
September 16, 2025 at 11:42 AM
The 2nd #Communicable & #Breakpoints collaboration drops on 19 Sept! Hosts @angelahuttner.bsky.social & @erinmccreary.bsky.social invite BALANCE trial leads Nick Daneman & Robert Fowler to discuss everything from the trial's humble start to its meteoric impact in clinical practice.
#IDSky #clinmicro
#IDSky #clinmicro
🆕 “Individualised duration of treatment in febrile urinary tract infection: ready for prime time?”
Excellent article just out by @jesusrbano.bsky.social and Zaira Palacios-Baena @lancetID.bsky.social👇
www.thelancet.com/journals/lan...
Excellent article just out by @jesusrbano.bsky.social and Zaira Palacios-Baena @lancetID.bsky.social👇
www.thelancet.com/journals/lan...
Individualised duration of treatment in febrile urinary tract infection: ready for prime time?
The duration of antimicrobial treatment is currently a hot topic in the field of infectious
diseases. For decades, the prevailing belief was that long treatments were essential
to prevent relapses. Th...
www.thelancet.com
September 14, 2025 at 8:43 PM
🆕 “Individualised duration of treatment in febrile urinary tract infection: ready for prime time?”
Excellent article just out by @jesusrbano.bsky.social and Zaira Palacios-Baena @lancetID.bsky.social👇
www.thelancet.com/journals/lan...
Excellent article just out by @jesusrbano.bsky.social and Zaira Palacios-Baena @lancetID.bsky.social👇
www.thelancet.com/journals/lan...
Reposted by Andre Kalil, MD MPH
Drs. Scherger, Gomez, Abbas, and @drandrekalil.bsky.social paired up for this review in @cmijournal.bsky.social for this narrative review on COVID-19 phenotypes #IDSky
www.clinicalmicrobiologyandinfection.org/article/S119...
www.clinicalmicrobiologyandinfection.org/article/S119...
Decoding COVID-19: Phenotypes and the Pursuit of Precision Medicine
The pursuit of personalized medicine has underscored the critical role of phenotypes
and sub-phenotypes in biology and medicine. A growing body of literature has identified
diverse phenotypic manifest...
www.clinicalmicrobiologyandinfection.org
September 8, 2025 at 5:46 PM
Drs. Scherger, Gomez, Abbas, and @drandrekalil.bsky.social paired up for this review in @cmijournal.bsky.social for this narrative review on COVID-19 phenotypes #IDSky
www.clinicalmicrobiologyandinfection.org/article/S119...
www.clinicalmicrobiologyandinfection.org/article/S119...
Reposted by Andre Kalil, MD MPH
Calls for editorial fellows for ESCMID's two journals, @cmijournal.bsky.social & @cmicomms.bsky.social, are closing soon! Don't miss the chance to be part of shaping and growing the journals and your career!
CMI (due 01 Sept): ow.ly/rifq50WBUfy
CMI Comms (due 15 Sept) ow.ly/F43F50WBUfw
#IDSky
CMI (due 01 Sept): ow.ly/rifq50WBUfy
CMI Comms (due 15 Sept) ow.ly/F43F50WBUfw
#IDSky
August 27, 2025 at 8:24 AM
Calls for editorial fellows for ESCMID's two journals, @cmijournal.bsky.social & @cmicomms.bsky.social, are closing soon! Don't miss the chance to be part of shaping and growing the journals and your career!
CMI (due 01 Sept): ow.ly/rifq50WBUfy
CMI Comms (due 15 Sept) ow.ly/F43F50WBUfw
#IDSky
CMI (due 01 Sept): ow.ly/rifq50WBUfy
CMI Comms (due 15 Sept) ow.ly/F43F50WBUfw
#IDSky
Reposted by Andre Kalil, MD MPH
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
Opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare neuroimmunological disorder with diverse etiologies, including infection-associated triggers such as human immunodeficiency virus (HIV) infection.
bit.ly
August 27, 2025 at 12:20 AM
Benefit of Early Oseltamivir Therapy for Adults Hospitalized With Influenza A: An Observational Study
Reposted by Andre Kalil, MD MPH
A Systematic Review and Meta-analysis of the Effectiveness of Remdesivir to Treat SARS-CoV-2 in Hospitalized Patients: Have the Guidelines Evolved With the Evidence?
A Systematic Review and Meta-analysis of the Effectiveness of Remdesivir to Treat SARS-CoV-2 in Hospitalized Patients: Have the Guidelines Evolved With the Evidence?
Clinical practice guidelines (CPGs) aim to reduce variability in practice in order to improve the quality of care by establishing best practice standards [1, 2]. With no definitive standardized approach to developing CPGs, there are inconsistencies in identifying, appraising, and synthesizing...
bit.ly
August 24, 2025 at 10:16 PM
A Systematic Review and Meta-analysis of the Effectiveness of Remdesivir to Treat SARS-CoV-2 in Hospitalized Patients: Have the Guidelines Evolved With the Evidence?
Reposted by Andre Kalil, MD MPH
Our two journals, CMI and CMI Communications, have open calls for editorial fellows. Read more about their respective programmes on their webpages and deadlines:
CMI @cmijournal.bsky.social ow.ly/HTBL50WBUfv
CMI Comms @cmicomms.bsky.social ow.ly/FJkF50WBUfz
#IDSky #clinmicro
CMI @cmijournal.bsky.social ow.ly/HTBL50WBUfv
CMI Comms @cmicomms.bsky.social ow.ly/FJkF50WBUfz
#IDSky #clinmicro
August 10, 2025 at 3:58 PM
Our two journals, CMI and CMI Communications, have open calls for editorial fellows. Read more about their respective programmes on their webpages and deadlines:
CMI @cmijournal.bsky.social ow.ly/HTBL50WBUfv
CMI Comms @cmicomms.bsky.social ow.ly/FJkF50WBUfz
#IDSky #clinmicro
CMI @cmijournal.bsky.social ow.ly/HTBL50WBUfv
CMI Comms @cmicomms.bsky.social ow.ly/FJkF50WBUfz
#IDSky #clinmicro
Reposted by Andre Kalil, MD MPH
Excited to share our work on the epidemiology of diarrheal pathogens using multiplex PCR gastrointestinal panels, led by the amazing medical student, Jeffrey Shu and now published in @cmijournal.bsky.social! 🎉 Kudos to all! #CCLCM #AWSOM shorturl.at/kTWqt
August 20, 2025 at 4:00 AM
Excited to share our work on the epidemiology of diarrheal pathogens using multiplex PCR gastrointestinal panels, led by the amazing medical student, Jeffrey Shu and now published in @cmijournal.bsky.social! 🎉 Kudos to all! #CCLCM #AWSOM shorturl.at/kTWqt
Reposted by Andre Kalil, MD MPH
September 2025 Issue is now online: www.clinicalmicrobiologyandinfection.org/issue/S1198-...
August 24, 2025 at 5:05 AM
September 2025 Issue is now online: www.clinicalmicrobiologyandinfection.org/issue/S1198-...
Reposted by Andre Kalil, MD MPH
#ASABreakpoint
In vitro, combos look powerful. In practice? Not always.
@angelahuttner.bsky.social reminds us “first, do no harm” Trials show limited benefit + higher toxicity
Are we relying too much on combo therapy in real-world care?
Read: www.asainc.net.au/newsletters/
@gardp.bsky.social #REVIVE
In vitro, combos look powerful. In practice? Not always.
@angelahuttner.bsky.social reminds us “first, do no harm” Trials show limited benefit + higher toxicity
Are we relying too much on combo therapy in real-world care?
Read: www.asainc.net.au/newsletters/
@gardp.bsky.social #REVIVE
August 22, 2025 at 10:25 AM
#ASABreakpoint
In vitro, combos look powerful. In practice? Not always.
@angelahuttner.bsky.social reminds us “first, do no harm” Trials show limited benefit + higher toxicity
Are we relying too much on combo therapy in real-world care?
Read: www.asainc.net.au/newsletters/
@gardp.bsky.social #REVIVE
In vitro, combos look powerful. In practice? Not always.
@angelahuttner.bsky.social reminds us “first, do no harm” Trials show limited benefit + higher toxicity
Are we relying too much on combo therapy in real-world care?
Read: www.asainc.net.au/newsletters/
@gardp.bsky.social #REVIVE
Reposted by Andre Kalil, MD MPH
The new #ASA #Breakpoint Newsletter is out🎉
🩺 Chris Robson’s PhD reshaping #infectiveendocarditis care
🔬 AUSCAST guidance on aminopenicillin breakpoints
📊 2024 AGAR: ESBL rates 📈
💊 @angelahuttner.bsky.social antibiotic combos
📷 Photo quiz: #unvaccinated infant
Read: www.asainc.net.au/newsletters
🩺 Chris Robson’s PhD reshaping #infectiveendocarditis care
🔬 AUSCAST guidance on aminopenicillin breakpoints
📊 2024 AGAR: ESBL rates 📈
💊 @angelahuttner.bsky.social antibiotic combos
📷 Photo quiz: #unvaccinated infant
Read: www.asainc.net.au/newsletters
August 22, 2025 at 10:10 AM
The new #ASA #Breakpoint Newsletter is out🎉
🩺 Chris Robson’s PhD reshaping #infectiveendocarditis care
🔬 AUSCAST guidance on aminopenicillin breakpoints
📊 2024 AGAR: ESBL rates 📈
💊 @angelahuttner.bsky.social antibiotic combos
📷 Photo quiz: #unvaccinated infant
Read: www.asainc.net.au/newsletters
🩺 Chris Robson’s PhD reshaping #infectiveendocarditis care
🔬 AUSCAST guidance on aminopenicillin breakpoints
📊 2024 AGAR: ESBL rates 📈
💊 @angelahuttner.bsky.social antibiotic combos
📷 Photo quiz: #unvaccinated infant
Read: www.asainc.net.au/newsletters
Reposted by Andre Kalil, MD MPH
My editorial in JAMA Health Forum: To support the academic research enterprise, we should pursue regulatory reforms that enable institutions to advance more of their discoveries to patients and, in doing so, capture more economic value of innovations they achieve
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Securing America’s Pharmaceutical Innovation Edge
This JAMA Forum discusses challenges to the US’s standing as a global leader in biomedical innovation from China, in the context of recent reductions in funding for biomedical research by the federal ...
jamanetwork.com
August 21, 2025 at 6:18 PM
My editorial in JAMA Health Forum: To support the academic research enterprise, we should pursue regulatory reforms that enable institutions to advance more of their discoveries to patients and, in doing so, capture more economic value of innovations they achieve
jamanetwork.com/journals/jam...
jamanetwork.com/journals/jam...
Reposted by Andre Kalil, MD MPH
Excited to be a part of this great group of collaborators on this latest work on blood culture contamination & BCx practices across 52 centers
Tons of credit to Valeria Fabre for leading this group!
#IDSky
journals.asm.org/doi/full/10....
Tons of credit to Valeria Fabre for leading this group!
#IDSky
journals.asm.org/doi/full/10....
Multicenter evaluation of blood culture contamination and blood cultures practices in US acute care hospitals: time for standardization | Journal of Clinical Microbiology
Blood culture contamination (BCC) is associated with patient harm and unnecessary
use of healthcare resources. BCC thresholds have been established; however, multiple
BCC definitions exist. There is l...
journals.asm.org
July 17, 2025 at 2:51 PM
Excited to be a part of this great group of collaborators on this latest work on blood culture contamination & BCx practices across 52 centers
Tons of credit to Valeria Fabre for leading this group!
#IDSky
journals.asm.org/doi/full/10....
Tons of credit to Valeria Fabre for leading this group!
#IDSky
journals.asm.org/doi/full/10....
Reposted by Andre Kalil, MD MPH
It was such a pleasure to be a part of this manuscript!
💥🆕“How to approach a patient hospitalized for pneumonia who is not responding to treatment?”
@intenscaremed.bsky.social
👇Free Access
bit.ly/3HdzxNI
#IDSky #MedSky #PCCSky #ICUSky #emimcc #Ansky #EMSky #AMSSky #Pharmsky #Pharmed #RXSky #MicroSky #ClinMicro@unmc.bsky.social@unmccom.bsky.social
@intenscaremed.bsky.social
👇Free Access
bit.ly/3HdzxNI
#IDSky #MedSky #PCCSky #ICUSky #emimcc #Ansky #EMSky #AMSSky #Pharmsky #Pharmed #RXSky #MicroSky #ClinMicro@unmc.bsky.social@unmccom.bsky.social
How to approach a patient hospitalized for pneumonia who is not responding to treatment? - Intensive Care Medicine
Pneumonia is a frequent cause of intensive care unit (ICU) admission and is the most common infection in ICU patients across all geographic regions. It takes 48-72h for most patients to respond to app...
bit.ly
July 16, 2025 at 2:19 PM
It was such a pleasure to be a part of this manuscript!